Searched for
IPCA SHARE PRICE
Vanguard slashes Ola value; War chokes PCB supplyAmerican investor Vanguard has sharply cut the fair value of Ola's parent company. This and more in today's ETtech Top 5.- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...
- Two Trades for Today: Two pharma stocks, one a large-cap for a 6.75% gain, the other a mid-cap for an almost 6% upmoveOur technical analysts identify select stocks that may gain momentum even in volatile markets. Here are the technical calls for today.
- Buy Ipca Laboratories, target price Rs 1,980: Motilal Oswal Financial ServicesMotilal Oswal Financial Services recommends buying Ipca Laboratories with a target price of Rs 1980. The company reported strong quarterly ...
- Ipca Laboratorties promoter sells 1.6% stake for Rs 600 croreUsha Madhukar Chandurkar, one of the promoters of Ipca Laboratories, on Wednesday divested a 1.6 per cent stake in the pharmaceutical compa...
- Reduce Ipca Labs, target price Rs 1,250: Prabhudas LilladherIpca Labs (IPCA) Q1 EBITDA of Rs 3.9 bn was in line with our estimate. Management guidance of 9% revenue growth (excluding Unichem) was bel...
- Ipca Labs falls 3% after USFDA issues Form 483 to API unitShares of Indian pharmaceutical company, Ipca Laboratories, fell by 3% after the US Food and Drug Administration (USFDA) issued a Form 483 ...
- Big Movers on D-St: What should investors do with KEI Industries, Ipca Laboratories and GSFC?The Indian market closed higher on Wednesday, with S&P BSE Sensex up over 150 points and Nifty50 above 17800 levels. The buying was seen in...
- Ipca Labs shares tumble 9% on acquisition of stake in Unichem LaboratoriesIpca Laboratories has agreed to buy 33.38% of the paid-up equity share capital of Unichem Laboratories for INR1,034.06 crore ($160m). The a...
- Chart Check: Ipca Laboratories gives a breakout from a falling trend line resistance; time to buy?Ipca Laboratories, a pharma company, is a potential buy as it has recorded a breakout from a falling trendline resistance and a Cup & Handl...
- Hold Ipca Laboratories, target price Rs 865: Prabhudas LilladherAt CMP, the stock is trading at 23x FY25E factoring in near term recovery.
- Big Movers on D-St: What should investors do with Apollo Hospitals, Adani Power and IPCA Laboratories?Stocks that were in focus on Thursday include names like Apollo Hospitals, Adani Power, and IPCA Laboratories.
- Ipca Labs Q3 results: Profit up 24% to Rs 197 croreTotal income also rose to Rs 1,230.99 crore for the quarter under consideration.
- Buy Ipca Laboratories, target Rs 915: NomuraBuy Ipca Laboratories Ltd. at a price target of Rs 915.
- Buy Ipca Laboratories, target Rs 837: Prabhudas LilladherBuy Ipca Laboratories Ltd. at a price target of Rs 837.0 .
- Outperform Ipca Laboratories, target Rs 920: IDFC SecuritiesOutperform Ipca Laboratories Ltd. at a price target of Rs 920.
Load More
